Ocugen to co-develop Bharat Biotech's Covid-19 vaccine candidate for US
The vaccine candidate, Covaxin, is currently in a late-stage study in India
Small bottles labelled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Drug developer Ocugen Inc will co-develop India-based Bharat Biotech's Covid-19 vaccine candidate for the US market, the companies said on Tuesday.
The vaccine candidate, Covaxin, is currently in a late-stage study in India.
Keep updated, follow The Business Standard's Google news channel
